MRNA Competitors & Alternatives

Compare Moderna Inc with similar stocks in the same industry

Biotechnology

MRNA

Main Stock
$195.00
-2.17%
Tradestie Score
44
Market Cap
$10.74B
Revenue Growth
29.2%
Analyst Upside
-15.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 6/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: mRNA platform, Lipid nanoparticles, AI sequence optimization
Major Customers 5
Governments Hospitals Pharmacies Distributors (e.g. McKesson) Healthcare providers
Critical Suppliers 4
Lipid nanoparticle suppliers Nucleotide raw material providers Contract manufacturing organizations Chemical synthesis partners
Direct Ecosystem Rivals 3

Top Competitors

212 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VRTX Vertex Pharmaceuticals Inc
$515.02
-1.08%
$103.64B 33.5 41 Compare
REGN Regeneron Pharmaceuticals Inc
$920.69
-0.29%
$63.59B 20.4 45 Compare
ALNY Alnylam Pharmaceuticals, Inc.
$143.82
-2.71%
$60.38B 7.5 63 Compare
ARGX argenx SE American Depositary Shares
$925.70
-1.73%
$46.96B 32.6 50 Compare
ONC BeOne Medicines Ltd. American Depositary Shares
$390.94
-2.19%
$36.81B 51.2 49 Compare
INSM Insmed, Inc.
$141.33
-2.17%
$31.13B - 39 Compare
BNTX BioNTech SE American Depositary Share
$80.96
-0.52%
$24.57B - 44 Compare
ZM Zoom Communications, Inc. Class A Common Stock
$81.26
-3.05%
$24.33B 7.8 45 Compare
GMAB Genmab A/S ADS
$50.60
-1.46%
$19.56B 43.9 42 Compare
NIO NIO Inc. American depositary shares, each representing one Class A ordinary share
$2.45
-7.89%
$18.85B - 44 Compare

Data updated: Nov 21, 2026 | Industry: Biotechnology (SIC 2836)

212 stocks in this industry